维普中文期刊产品整合服务
91篇 您的检索式:作者名="Henderson IC"
    题名 作者 年代 出处 被引量
1Estrogenreceptor status and outcomes of modem chemotherapy for patients with node-positive breast cancer 显示文摘Berry DA Cirrincione C Henderson IC 2006JAMA2006,295,14:1
2Improved outcomes from adding sequential paclitaxel but not from escalating doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer显示文摘Henderson IC Berry DA Demetri GD 2003J Clin Oncol2003,21,6:1
3Improved outcomes from adding sequential paclitaxel but not from eslating doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer 显示文摘Henderson IC Berry D Demetri GD 2003J Clin Oncol2003,21,6:1
4Estrogen-receptor status and outcomes of moderm chemotherapy for patients with node-positive breast cancer显示文摘Berry DA Cirrincione C Henderson IC 2006JAMA2006,295,14:1
5Improved outcomes from adding sequential paclixaxel but not from escalating doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer显示文摘Henderson IC Berry DA Demetri GD 2003J Clin Oncol2003,21,8:1
6Improved outcomes from adding sequential paclitaxel but not from eslatingdoxorubicin dose in an adjuvant chemotherapy regimen for patient with nodepositive primary breast cancer 显示文摘Henderson IC Berry D Demetri GD 2003J Clin Oncol2003,21,6:1
7Estrogen recep tor status and outcomes of modern chemotherapy for patients with node-positive breast cancer 显示文摘Berry DA Cirrincione C Henderson IC 2006JAMA2006,295,14:1
8Improved outcomes from adding sequential Paclitaxel but not from escalating Doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer显示文摘Henderson IC Berry DA Demetri GD 2003J Clin Oncol2003,21,6:1
9Estrogen-receptor sta- tus and outcomes of modem chemotherapy for patients with nodepositive breast cancer显示文摘Berry DA Cirrincione C Henderson IC 2006JAMA2006,295,14:1
10Improved outcomes from adding sequential paclitaxel but not from eslating doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer显示文摘Henderson IC Berry D Demetri GD 2003J Clin Oncol2003,21,6:1
11Estrogen-Receptor Status and Outcomes of Modern Chemotherapy for Patients With Node-Positive Breast Cancer显示文摘Berry DA Cirrincione C Henderson IC 2006JAMA2006,295,14:1
12Improved outcomes from adding sequential paclitaxel but not from escalating doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer显示文摘Henderson IC Berry DA Demetri GD 2003J Clin Oncol2003,21,6:1
13Estrogen-receptor status and outcomes of modem chemotherapy for patients with node-positive breast cancer显示文摘Berry DA Cirrincione C Henderson IC 0,,:1
14Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer 显示文摘Berry DA Cirrincione C Henderson IC 2006JAMA2006,295,14:1
15Estrogenorecep-tor status and outcomes of modern chemotherapy for patients with node-positive breast cancer显示文摘Berry DA Cirrincione C Henderson IC 2006JAMA2006,295,14:1
16Estrogenreceptor status and outcomes of modem chemotherapy for patients with node - posi- tive breast cancer 显示文摘Berry DA Cirrincione C Henderson IC 2006JAMA2006,295,14:1
17Improved outcomes from adding sequential Paclitaxel but not from escalating Doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer显示文摘Henderson IC Berry DA Demetri GD 2003J Clin Oncol2003,21,6:1
18Risk factors for breast cancer development显示文摘Henderson IC 1993Cancer1993,71,6:1
19Estrogen-receptor sta- tus and outcomes of modem chemotherapy for patients with node- positive breast cancer 显示文摘Berry DA Cirrincionc C Henderson IC 2006JAMA2006,295,14:1
20Estrogen -receptor status and outcomes of modem chemotherapy forpatients with node-positive breast cancer 显示文摘Berry DA Cinincione C Henderson IC 2006JAMA2006,295,14:1
返回顶部 每页显示:
共5页 首页 上一页 第1页 下一页 末页 /5 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费